Diffuse Cutaneous Leishmaniasis Caused by Leishmania major as the Initial Presentation of HIV Misdiagnosed as Scabies and Kaposi’s Sarcoma: A Case Report
,
Abstract
Diffuse cutaneous leishmaniasis (DCL) is a rare and severe form of cutaneous leishmaniasis (CL), particularly uncommon in Uzbekistan. Leishmaniasis remains a major opportunistic infection in immunocompromised individuals, especially in those with HIV, where co-infection with Leishmania spp. can result in atypical clinical manifestations, delayed diagnosis, and poor treatment response. This is a retrospective descriptive case report of a single pediatric patient. We report the first known case of DCL in an HIV-infected pediatric patient in Uzbekistan. A 14-year-old boy presented with multiple, non-ulcerative, progressively worsening skin lesions on the face and extremities over six months. Although he had no travel history to known endemic areas, he resided in a region with reported local transmission. Physical examination revealed extensive infiltrative plaques and nodules. Laboratory investigations, including Giemsa staining and PCR, confirmed Leishmania infection. Histopathological analysis showed both intravascular and extravascular amastigotes, and species identification revealed L. major. Imaging ruled out visceral involvement. Given the patient’s immunosuppressed status and the disseminated skin involvement, a diagnosis of DCL was established. Liposomal amphotericin B was initiated as first-line therapy. This case illustrates the diagnostic complexities of leishmaniasis in HIV-positive patients, where initial misdiagnoses (e.g., scabies or Kaposi’s sarcoma) may delay appropriate treatment. It highlights the critical need for heightened clinical suspicion, better diagnostic tools, and improved physician awareness in endemic and emerging transmission areas. In the context of rising HIV rates and growing domestic tourism to endemic zones, early screening and structured public health interventions are essential to reduce disease burden and improve patient outcomes in Uzbekistan.
2. Maroli M, Feliciangeli MD, Bichaud L, Charrel RN, Gradoni L. Phlebotomine sandflies and the spreading of leishmaniasis and other diseases of public health concern. Med Vet Entomol. 2013; 27:123–47.
3. Mokni M. Cutaneous leishmaniasis. Ann Dermatol Venereol. 2019; 146: 232–246.
4. World Health Organization (2008) The Global Burden of Disease: 2004 update. Geneva, Switzerland: World Health Organization. 84 p.
5. Alam MZ, Kovalenko DA, Kuhls K, et al. Identification of the agent causing visceral leishmaniasis in Uzbeki and Tajiki foci by analyzing parasite DNA extracted from patients' Giemsa-stained tissue preparations. Parasitology. 2009;136(9):981-6.
6. Kovalenko DA, Razakov SA, Ponirovsky EN, et al. Canine leishmaniosis and its relationship to human visceral leishmaniasis in Eastern Uzbekistan. Parasit Vectors. 2011; 4:58.
7. Usarov GX, Turitsin VS, Sattarova XG, et al. Phlebotomine sand fly (Diptera: Phlebotominae) diversity in the foci of cutaneous leishmaniasis in the Surxondaryo Region of Uzbekistan: 50 years on. Parasitol Res. 2024;123(3):170.
8. World Health Organization. Number of cases of cutaneous and visceral leishmaniasis reported (Internet). Geneva: World Health Organization; (cited 2025 January 22). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/number-of-cases-of-cutaneous-leishmaniasis-reported
9. World Health Organization. Number of cases of cutaneous and visceral leishmaniasis reported (Internet). Geneva: World Health Organization; (cited 2025 January 22). Available from: https://www.who.int/data/gho/data/indicators/indicator-details/GHO/number-of-cases-of-visceral-leishmaniasis-reported
10. Burza S, Croft SL, Boelaert M (2018). Leishmaniasis. Lancet. 2018; 392(10151):951-970.
11. van Henten S, Adriaensen W, Fikre H, et al. Cutaneous leishmaniasis due to Leishmania aethiopica. EClinicalMedicine. 2019; 6:69-81.
12. Azeredo-Coutinho RB, Conceição-Silva F, Schubach A, et al. First report of diffuse cutaneous leishmaniasis and Leishmania amazonensis infection in Rio de Janeiro State, Brazil. Trans R Soc Trop Med Hyg. 2007;101(7):735–737.
13. Hajjaran H, Mohebali M, Akhavan AA, et al. Unusual presentation of disseminated cutaneous leishmaniasis due to Leishmania major: Case reports of four Iranian patients. Asian Pac J Trop Med. 2013; 6(4):333-6.
14. Artamonova OG, Monchakovskaya ES, Kubanov AA, et al. A rare form of leishmaniasis, identified in the Russian Federation. Vestnik Dermatologii i Venerologii. 2023;99(3):79–86.
15. Gelanew T, Hurissa Z, Diro E, et al. Disseminated cutaneous leishmaniasis resembling post-kala-azar dermal leishmaniasis caused by Leishmania donovani in three patients co-infected with visceral leishmaniasis and human immunodeficiency virus/acquired immunodeficiency syndrome in Ethiopia. Am J Trop Med Hyg. 2011;84(6):906-12.
16. Badirzadeh AR, Mohebali M, Sabzevari S, et al. Case Report: First Coinfection Report of Mixed Leishmania infantum/Leishmania major and Human Immunodeficiency Virus–Acquired Immune Deficiency Syndrome: Report of a Case of Disseminated Cutaneous Leishmaniasis in Iran. Am J Trop Med Hyg, 2018; 98(1):122–125.
17. Aronson N, Herwaldt BL, Libman M, et al. Diagnosis and Treatment of Leishmaniasis: Clinical Practice Guidelines by the Infectious Diseases Society of America (IDSA) and the American Society of Tropical Medicine and Hygiene (ASTMH). Am J Trop Med Hyg. 2017;96(1):24-45.
18. Khamdamov BZ, Rasulova IA, Khamdamov AB. Clinical and epidemiological features of cutaneous leishmaniasis in the regions of Uzbekistan. JournalNX: A Multidisciplinary Peer Reviewed Journal. 2022; 8(4):169-173.
19. Shafiei R, Mohebali M, Akhoundi B, et al. Emergence of coinfection of visceral leishmaniasis in HIV-positive patients in northeast Iran: a preliminary study. Travel Med Infect Dis. 2014; 12(2):173–178.
20. Kassardjian AA, Yim KM, Rabi S, et al. Diffuse cutaneous leishmaniasis and HIV co-infection: A case report and review of the literature. J Cutan Pathol. 2021;48(6):802–806.
21. Jafari S, Hajiabdolbaghi M, Mohebali M, et al. Disseminated leishmaniasis caused by Leishmania tropica in HIV-positive patients in the Islamic Republic of Iran. East Mediterr Health J. 2010; 16(3): 340–343.
22. Nissapatorn V, Sawangjaroen N. Parasitic infections in HIV infected individuals: diagnostic & therapeutic challenges. Indian J Med Res. 2011; 134(6):878-97.
23. Van Griensven J, Carrillo E, López-Vélez R, et al. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014; 20(4):286-99.
| Files | ||
| Issue | Vol 20 No 3 (2025) | |
| Section | Case Report(s) | |
| Keywords | ||
| Diffuse cutaneous leishmaniasis HIV co-infection Pediatric leishmaniasis Leishmania major Opportunistic infection Uzbekistan | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
